Bio-Rad Laboratoriesvs.Labcorp
BIO vs LH · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Labcorp is about 2.9× larger than Bio-Rad Laboratories by market cap; Labcorp trades at the lower P/E (24.1 vs 47.1); year to date, Labcorp leads (+10.3% vs −2.3%).
Side by side
| BIO | LH | |
|---|---|---|
| Market cap | $8B | $22.7B |
| Price | $296.11 | $276.81 |
| Today | −0.4% | −0.3% |
| Return YTD | −2.3% | +10.3% |
| Return 1Y | +13.9% | +9.1% |
| P/E | 47.1 | 24.1 |
| P/S | 3.1 | 1.6 |
| P/B | 1.2 | 2.6 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Bio-Rad LaboratoriesBIO
American manufacturer of products for clinical diagnostics and life science research — including blood typing and droplet digital PCR.
Full BIO profile →LabcorpLH
One of the largest US clinical laboratory networks plus contract research.
Full LH profile →More comparisons in Diagnostics
See where BIO and LH sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →